Stay updated on Itolizumab in Uncontrolled Asthma Clinical Trial
Sign up to get notified when there's something new on the Itolizumab in Uncontrolled Asthma Clinical Trial page.

Latest updates to the Itolizumab in Uncontrolled Asthma Clinical Trial page
- CheckyesterdayChange DetectedThe study record for the completed itolizumab asthma trial is displayed, including its design, eligibility criteria, locations, outcome measures, and supporting documents.SummaryDifference53%

- Check8 days agoChange DetectedThe footer’s site revision label changed from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check15 days agoChange DetectedA banner announces that NIH is transitioning from using “Artificial Intelligence” to “Super Intelligence” terminology and links to updates and FAQs.SummaryDifference1%

- Check22 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.1 to v3.7.2, while the page continues to display a 403 error.SummaryDifference0.2%

- Check29 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check43 days agoChange DetectedThe 403 Forbidden page content and its surrounding HTML, including the link to Home, were removed, eliminating the explicit 403 error display from the page.SummaryDifference0.5%

Stay in the know with updates to Itolizumab in Uncontrolled Asthma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Itolizumab in Uncontrolled Asthma Clinical Trial page.